OverT Bio: Funding, Investors & Team (Sep 2026)
OverT Bio is a biotech company that offers cell therapy for cancer. The company specializes in creating innovative genetic modifications to help immune cells combat tumor barriers, resulting in more successful and long-lasting immunotherapy treatments for cancer patients. This allows the healthcare sector to better diagnose and treat cancer.
OverT Bio has raised $16.1M across 2 funding rounds on record, the most recent an undisclosed round of $120k announced in Nov 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
OverT Bio Company Profile and Key Stats
Latest funding round on record: Nov 2024.
OverT Bio Funding Rounds
OverT Bio raised $16.0M in a Seed announced in May 2024.
6 months later, an undisclosed round of $120k was announced in Nov 2024.
OverT Bio Founders and Leadership Team
No contact details are on record for this team yet.
OverT Bio Funding Compared to Other Biotechnology Startups
OverT Bio's latest round of $120k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like OverT Bio in Biotechnology and New York
Companies Similar to OverT Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
OverT Bio Funding FAQs
What does OverT Bio do?
OverT Bio is a biotech company that offers cell therapy for cancer. The company specializes in creating innovative genetic modifications to help immune cells combat tumor barriers, resulting in more successful and long-lasting immunotherapy treatments for cancer patients. This allows the healthcare sector to better diagnose and treat cancer.
How much funding has OverT Bio raised?
OverT Bio has raised $16.1M across 2 rounds on record. The most recent is an undisclosed round of $120k announced in Nov 2024.
When did OverT Bio last raise funding?
OverT Bio's most recent funding round on record is an undisclosed round of $120k, announced in Nov 2024.
Who founded OverT Bio?
FundedIQ lists Mat Legut (Founder) at OverT Bio.
Where is OverT Bio headquartered?
OverT Bio is based in New York, United States.
How many employees does OverT Bio have?
OverT Bio is in the 1-10 employee band.
How does OverT Bio's funding compare to other Biotechnology startups?
OverT Bio's latest round of $120k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's OverT Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for OverT Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.